DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
Objective of study: refining immune diagnostics of systemic scleroderma through determining ceruloplasmin antibodies, its amount and enzymatic activity, as well as control of effectiveness of therapy with ceruloplasmin-based immobilized magnetocontrollable immunosorbents.Materials and methods. 30 ap...
Enregistré dans:
Auteurs principaux: | O. I. Emelyanova, I. P. Gontar, O. A. Rusanova, I. A. Zborovskaya |
---|---|
Format: | article |
Langue: | RU |
Publié: |
SPb RAACI
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d61a3e8d79364395a4618f2a8751e211 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
par: O. I. Emelyanova, et autres
Publié: (2021) -
A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES
par: A. V. Sokolov, et autres
Publié: (2018) -
Assessment of serum selenium and ceruloplasmin in potentially malignant disorders and oral cancer
par: Mathew O Mampilly, et autres
Publié: (2021) -
Translational control of ceruloplasmin gene expression: Beyond the IRE
par: MAZUMDER,BARSANJIT, et autres
Publié: (2006) -
Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review
par: Francesca Rosamilia, et autres
Publié: (2021)